MENU

Continuing Education Credits

Earn Continuing Education (CE) credits from OncomineWorld presentations! Attend a live or on demand session to obtain your credits.

The speakers below have been approved for Continuing Education Credits. To redeem your credits, locate the presentation you watched and click on the CE buttons for further direction. For more general information regarding continuing education, the processes to receive credits, and the accreditation bodies, click here. CE credits are recognized by several accreditation bodies but may not be applicable in all countries.


MAR 20 - 21 2024

OncomineWorld 2024: A Virtual NGS Education Meeting

New live presentations are coming March 2024! Since 2020, OncomineWorld meetings have brought together thousands of scientists and professionals from around the world each year to advance genomic profiling in clinical oncology research.

Attend one of our three live sessions to enjoy presentations spanning a variety of clinical oncology research topics and engage in Q&A with the speakers. Presentations will explore liquid biopsy applications, comprehensive genomic profiling, and NGS profiling for myeloid malignancies, among many other topics.

In addition to new presentations, here are some additional event features you can look forward to exploring:


  • Interactive Virtual Laboratories: Explore the many applications of NGS for precision oncology research, including emerging NSCLC biomarkers, comprehensive genomic profiling (CGP), liquid biopsy research, and hemato-oncology research
  • Oncomine Clinical Research Grant Hall: See how Thermo Fisher Scientific supports molecular profiling in oncology research and learn about upcoming calls for grant applications
  • Ion Torrent Genexus NGS System Demonstrations: Learn more about the fast, easy, automated end-to-end next-generation sequencing workflow that delivers NGS test results in as little as 24 hours

  •  

Earn Continuing Education (CE) credits as you:

  • Gain a deeper understanding of the diverse applications of next-generation sequencing (NGS) in clinical oncology research
  • Explore the latest important biomarkers in clinical oncology research, such as HER2 and EGFR exon 20 insertions, and gain insights into the advantages and limitations of various testing techniques
  • Uncover the remarkable ease, simplicity, and speed at which NGS can revolutionize your work, while acquiring valuable tools to explore its vast possibilities

Speakers
  • Moderator | Philip Jermann, PhD

    CSD Medical Affairs Director EMEA, Thermo Fisher Scientific
    BIOGRAPHY
  • Moderator | Luca Quagliata, PhD, MCMAS, COA

    Vice President and Global Head of Medical Affairs, Thermo Fisher Scientific
    BIOGRAPHY
  • Dr. Glenn Francis, MBBS(Hons) FRCPA MBA FFSc(RCPA) PhD

    Medical Director, Genomics for Life, Queensland, Australia
    BIOGRAPHY
  • Dr. Ting Chan, PhD

    Curation Scientist, Centre for Cancer Research, University of Melbourne, Melbourne, Australia
    BIOGRAPHY
  • Dr. Michael Krigstein, MBBS(Hons) FRACP FRCPA MCncrSc

    Consultant Haematologist, SydPath, St Vincent's Hospital, Sydney, Australia
    BIOGRAPHY
  • Dr. James Beasley, DClinSci, MSc

    Principal Clinical Scientist, West Midlands Regional Genetics Service, Birmingham, England, UK
    BIOGRAPHY
  • Maximilian Prinz-Wohlgenannt, BSc, MSc

    Head of Molecular Biology, Landesklinikum Horn - Allentsteig, Horn, Austria
    BIOGRAPHY
  • Dr. Nicola Normanno, MD

    Scientific Director, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST), "Dino Amadori", Meldola, Italy
    BIOGRAPHY
  • Dr. Daniel Lock, PhD

    Clinical Scientist, LTHT Hematological Malignancy Diagnostic Service, Leeds, England, UK
    BIOGRAPHY
  • Dr. Philip Sander, Dr rer nat

    Laboratory Manager, NGS Diagnostics, T-BAG Molecular Pathology Baden-Württemberg, Stuttgart, Germany
    BIOGRAPHY
  • Dr. Wang Cheung, MD PhD

    Pathologist, Orlando Regional Hospital, Orlando, FL, USA
  • Gary Pestano, PhD

    Chief Development Officer, NYS CLEP Laboratory Director, Biodesix Inc., Louisville, CO
    BIOGRAPHY
  • Andrea Ferreira-Gonzalez, PhD

    Professor of Pathology, Chair of Molecular Diagnostics Division, Virginia Commonwealth University, Richmond, Virginia, USA

Agenda

In addition to the content from our 2024 speakers featured below, access dozens of on-demand presentations from past OncomineWorld meetings, too!

  • Experience using the ODxET-Assay with focus on lung cancer samples - FFPE and liquid biopsy
    MAR 21, 2024 4:05 PM CET

    Experience using the ODxET-Assay with focus on lung cancer samples - FFPE and liquid biopsy

    Dr. Philip Sander, Dr rer nat
    Laboratory Manager, NGS Diagnostics, T-BAG Molecular Pathology Baden-Württemberg, Stuttgart, Germany
    BIOGRAPHY
  • A high-throughput NGS screen for myeloproliferative neoplasms (MPN)
    MAR 21, 2024 3:35 PM CET

    A high-throughput NGS screen for myeloproliferative neoplasms (MPN)

    Dr. Daniel Lock, PhD
    Clinical Scientist, LTHT Hematological Malignancy Diagnostic Service, Leeds, England, UK
    BIOGRAPHY
    Continuing Education: P.A.C.E. CE | Florida CE
  • Maximizing clinical utility of rapid NGS testing
    MAR 21, 2024 3:35 PM CET

    Maximizing clinical utility of rapid NGS testing

    Dr. James Beasley, DClinSci, MSc
    Principal Clinical Scientist, West Midlands Regional Genetics Service, Birmingham, England, UK
    BIOGRAPHY
    Continuing Education: P.A.C.E. CE | Florida CE
  • Experiences with the OncomineTM Myeloid Assay v2 and the Analytical Validation Service in clinical research
    MAR 21, 2024 3:05 PM CET

    Experiences with the OncomineTM Myeloid Assay v2 and the Analytical Validation Service in clinical research

    Maximilian Prinz-Wohlgenannt, BSc, MSc
    Head of Molecular Biology, Landesklinikum Horn - Allentsteig, Horn, Austria
    BIOGRAPHY
    Continuing Education: P.A.C.E. CE | Florida CE
  • HRD testing in ovarian cancer samples using comprehensive genomic profiling
    MAR 21, 2024 3:05 PM CET

    HRD testing in ovarian cancer samples using comprehensive genomic profiling

    Dr. Nicola Normanno, MD
    Scientific Director, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST), "Dino Amadori", Meldola, Italy
    BIOGRAPHY
  • Welcome
    MAR 21, 2024 3:00 PM CET

    Welcome

    Moderator | Luca Quagliata, PhD, MCMAS, COA
    Vice President and Global Head of Medical Affairs, Thermo Fisher Scientific
    BIOGRAPHY
  • Welcome
    MAR 21, 2024 3:00 PM CET

    Welcome

    Moderator | Philip Jermann, PhD
    CSD Medical Affairs Director EMEA, Thermo Fisher Scientific
    BIOGRAPHY
  • Empowering precision oncology through localized comprehensive genomic tumor profiling
    MAR 21, 2024 1:05 PM PDT

    Empowering precision oncology through localized comprehensive genomic tumor profiling

    Andrea Ferreira-Gonzalez, PhD
    Professor of Pathology, Chair of Molecular Diagnostics Division, Virginia Commonwealth University, Richmond, Virginia, USA
    Continuing Education: P.A.C.E. CE | Florida CE
  • Utility of NGS in Lymphoid Malignancies and Ion AmpliSeq™ Liverpool Lymphoid Network Panel experience
    MAR 21, 2024 1:00 PM SGT

    Utility of NGS in Lymphoid Malignancies and Ion AmpliSeq™ Liverpool Lymphoid Network Panel experience

    Dr. Michael Krigstein, MBBS(Hons) FRACP FRCPA MCncrSc
    Consultant Haematologist, SydPath, St Vincent's Hospital, Sydney, Australia
    BIOGRAPHY
  • Oncomine Precision Assay: Automated and decentralized genomic profiling of plasma cell-free DNA
    MAR 21, 2024 12:35 PM SGT

    Oncomine Precision Assay: Automated and decentralized genomic profiling of plasma cell-free DNA

    Dr. Ting Chan, PhD
    Curation Scientist, Centre for Cancer Research, University of Melbourne, Melbourne, Australia
    BIOGRAPHY
    Continuing Education: P.A.C.E. CE | Florida CE
  • Community-based testing experiences with the GeneStrat NGS liquid biopsy test
    MAR 21, 2024 12:30 PM PDT

    Community-based testing experiences with the GeneStrat NGS liquid biopsy test

    Gary Pestano, PhD
    Chief Development Officer, NYS CLEP Laboratory Director, Biodesix Inc., Louisville, CO
    BIOGRAPHY
    Continuing Education: P.A.C.E. CE | Florida CE
  • An experience with in-house NGS for solid tumor testing
    MAR 21, 2024 12:05 PM PDT

    An experience with in-house NGS for solid tumor testing

    Dr. Wang Cheung, MD PhD
    Pathologist, Orlando Regional Hospital, Orlando, FL, USA
    Continuing Education: P.A.C.E. CE | Florida CE
  • New Horizons in Genomic Pathology: Utilization and Requirements for Successful Tumour Testing Using FFPE Samples
    MAR 21, 2024 12:05 PM SGT

    New Horizons in Genomic Pathology: Utilization and Requirements for Successful Tumour Testing Using FFPE Samples

    Dr. Glenn Francis, MBBS(Hons) FRCPA MBA FFSc(RCPA) PhD
    Medical Director, Genomics for Life, Queensland, Australia
    BIOGRAPHY
  • Welcome
    MAR 21, 2024 12:00 PM SGT

    Welcome

    Moderator | Luca Quagliata, PhD, MCMAS, COA
    Vice President and Global Head of Medical Affairs, Thermo Fisher Scientific
    BIOGRAPHY
  • Welcome
    MAR 21, 2024 12:00 PM PDT

    Welcome

    Moderator | Luca Quagliata, PhD, MCMAS, COA
    Vice President and Global Head of Medical Affairs, Thermo Fisher Scientific
    BIOGRAPHY
  • MAR 30, 2023 5:10 PM CEST

    Molecular analysis in the diagnosis and prognosis of haematological malignancies

    Dr. Geetha Menon, MD
    Clinical Director, Haemato-oncology Diagnostic Service...
    Lihui Wang, PhD
    Lead, Haemato-oncology Diagnostic Service (HODS) Cheshi...
  • Ion Torrent™ Oncomine™ Dx Express Test - Multiple sites evaluation results and routine experience
    MAR 30, 2023 4:45 PM CEST

    Ion Torrent™ Oncomine™ Dx Express Test - Multiple sites evaluation results and routine experience

    Paul Hofman, MD, PhD
    Professor of Pathology and Head of Laboratory of Clinical and Experimental Pathology at Louis Pasteur Hospital, Nice, France
    BIOGRAPHY
  • Feasibility of rapid lung NGS testing
    MAR 30, 2023 4:25 PM CEST

    Feasibility of rapid lung NGS testing

    Fernando López-Ríos, MD, PhD
    Department of Pathology, University Hospital October 12, Madrid, Spain
    BIOGRAPHY
  • Simultaneous DNA and RNA variant testing by Oncomine™ Precision Assay
    MAR 30, 2023 3:55 PM CEST

    Simultaneous DNA and RNA variant testing by Oncomine™ Precision Assay

    Annarita Destro, PhD
    Head of Molecular Pathology Department, Humanitas Research Hospital, Italy
    BIOGRAPHY
  • Oncomine Comprehensive Assay Plus - Genomic Instability Metrix (GIM)
    MAR 30, 2023 3:15 PM CEST

    Oncomine Comprehensive Assay Plus - Genomic Instability Metrix (GIM)

    Annette Staebler, MD
    Head of Gynecological Pathology and Mammary Pathology Division, University Hospital Tuebingen, Germany
    BIOGRAPHY
  • Genomic instability metric (GIM) for HRD assessment
    MAR 30, 2023 3:05 PM CEST

    Genomic instability metric (GIM) for HRD assessment

    Elaine Wong-Ho, PhD
    Sr. Product Manager, Oncology, Thermo Fisher Scientific
    BIOGRAPHY
  • Genexus System demonstration with live Q&A
    MAR 30, 2023 2:40 PM PDT

    Genexus System demonstration with live Q&A

    Andrew Hutchison
    Director, Instruments, Thermo Fisher Scientific
  • Comparative performance evaluation of the GeneStrat NGS™ liquid biopsy test for the detection of copy number amplifications, fusions/exon skipping, somatic single nucleotide variants and...
    MAR 30, 2023 1:50 PM PDT

    Comparative performance evaluation of the GeneStrat NGS™ liquid biopsy test for the detection of copy number amplifications, fusions/exon skipping, somatic single nucleotide variants and...

    Gary Pestano, PhD
    Chief Development Officer, NYS CLEP Laboratory Director, Biodesix Inc., Louisville, CO
    BIOGRAPHY
  • Evaluation of the Oncomine™ Comprehensive Assay v3 and early experience with the Oncomine Comprehensive Assay Plus on the Genexus™ System
    MAR 30, 2023 1:50 PM +08

    Evaluation of the Oncomine™ Comprehensive Assay v3 and early experience with the Oncomine Comprehensive Assay Plus on the Genexus™ System

    Dr. Bin Wang
    Senior Hospital Scientist, SydPath - St. Vincent's Hospital, Sydney, Australia
    BIOGRAPHY
  • Clinical impact of front-line NGS testing in patients with suspected myeloid malignancy
    MAR 30, 2023 1:20 PM PDT

    Clinical impact of front-line NGS testing in patients with suspected myeloid malignancy

    Bekim Sadikovic, PhD, DABMG, FACMG
    Professor, Research Chair, and Program Head, Western University and London Health Sciences, Ontario, Canada
    BIOGRAPHY
  • TCR repertoire profiling to predict NSCLC response to immunotherapy - feasibility study
    MAR 30, 2023 1:00 PM +08

    TCR repertoire profiling to predict NSCLC response to immunotherapy - feasibility study

    Elin Gray, BSc, MSc, PhD
    Associate Professor, Edith Cowan University, Australia
    BIOGRAPHY
  • Clinical utility of NGS in liquid biopsy for lung cancer (copy)
    MAR 30, 2023 12:25 PM +08

    Clinical utility of NGS in liquid biopsy for lung cancer (copy)

    Dr. Anuradha Chougule
    Consultant, Medical Oncology, Tata Memorial Hospital, Mumbai, India; Chair Professor (CoE), Cancer Research in Genetics, Maharashtra University of Health Sciences (MUHS), Maharashtra, India
    BIOGRAPHY
  • Clinical utility of amplicon-based comprehensive genomic profiling (CGP)
    MAR 30, 2023 12:25 PM PDT

    Clinical utility of amplicon-based comprehensive genomic profiling (CGP)

    Eric Vail, MD
    Director of Molecular Pathology, Cedars-Sinai Medical Center, Los Angeles, California
    BIOGRAPHY
  • Concordance of targeted sequencing from circulating tumor DNA and paired tumor tissue
    MAR 30, 2023 12:05 PM +08

    Concordance of targeted sequencing from circulating tumor DNA and paired tumor tissue

    Dr. Chi-Cheng Huang, PhD
    Director of Comprehensive Breast Health Center, Taipei Veterans General Hospital, Taiwan
    BIOGRAPHY
  • Rapid tissue-based molecular testing in oncology
    MAR 30, 2023 12:05 PM PDT

    Rapid tissue-based molecular testing in oncology

    Lauren Ritterhouse, MD, PhD
    Associate Director for the Center of Integrated Diagnostics, Massachusetts General Hospital, Boston, Massachusetts, Assistant Professor of Pathology, Harvard Medical School
    BIOGRAPHY
  • Asia Pacific Live Session: 12:00-13:35 SGT
  • Welcome
    MAR 21, 2024 12:00 PM SGT

    Welcome

    Moderator | Luca Quagliata, PhD, MCMAS, COA
    Vice President and Global Head of Medical Affairs, Thermo Fisher Scientific
    BIOGRAPHY
    • APJ, Part 1: General Education
    • New Horizons in Genomic Pathology: Utilization and Requirements for Successful Tumour Testing Using FFPE Samples
      MAR 21, 2024 12:05 PM SGT

      New Horizons in Genomic Pathology: Utilization and Requirements for Successful Tumour Testing Using FFPE Samples

      Dr. Glenn Francis, MBBS(Hons) FRCPA MBA FFSc(RCPA) PhD
      Medical Director, Genomics for Life, Queensland, Australia
      BIOGRAPHY
    • APJ, Part 2: Clinical Research
    • Oncomine Precision Assay: Automated and decentralized genomic profiling of plasma cell-free DNA
      MAR 21, 2024 12:35 PM SGT

      Oncomine Precision Assay: Automated and decentralized genomic profiling of plasma cell-free DNA

      Dr. Ting Chan, PhD
      Curation Scientist, Centre for Cancer Research, University of Melbourne, Melbourne, Australia
      BIOGRAPHY
      Continuing Education: P.A.C.E. CE | Florida CE
    • Utility of NGS in Lymphoid Malignancies and Ion AmpliSeq™ Liverpool Lymphoid Network Panel experience
      MAR 21, 2024 1:00 PM SGT

      Utility of NGS in Lymphoid Malignancies and Ion AmpliSeq™ Liverpool Lymphoid Network Panel experience

      Dr. Michael Krigstein, MBBS(Hons) FRACP FRCPA MCncrSc
      Consultant Haematologist, SydPath, St Vincent's Hospital, Sydney, Australia
      BIOGRAPHY
  • Europe and the Americas Live Session (Solid Tumor Track): 15:00-16:40 CET
  • Welcome
    MAR 21, 2024 3:00 PM CET

    Welcome

    Moderator | Luca Quagliata, PhD, MCMAS, COA
    Vice President and Global Head of Medical Affairs, Thermo Fisher Scientific
    BIOGRAPHY
    • EMEA, Part 1: Clinical Research for Solid Tumors
    • HRD testing in ovarian cancer samples using comprehensive genomic profiling
      MAR 21, 2024 3:05 PM CET

      HRD testing in ovarian cancer samples using comprehensive genomic profiling

      Dr. Nicola Normanno, MD
      Scientific Director, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST), "Dino Amadori", Meldola, Italy
      BIOGRAPHY
    • EMEA, Part 3: In Vitro Diagnostic Testing
    • Experience using the ODxET-Assay with focus on lung cancer samples - FFPE and liquid biopsy
      MAR 21, 2024 4:05 PM CET

      Experience using the ODxET-Assay with focus on lung cancer samples - FFPE and liquid biopsy

      Dr. Philip Sander, Dr rer nat
      Laboratory Manager, NGS Diagnostics, T-BAG Molecular Pathology Baden-Württemberg, Stuttgart, Germany
      BIOGRAPHY
  • EUROPE AND THE AMERICAS LIVE SESSION (Haematological Alignancy Track): 15:00-16:40 CET
  • Welcome
    MAR 21, 2024 3:00 PM CET

    Welcome

    Moderator | Philip Jermann, PhD
    CSD Medical Affairs Director EMEA, Thermo Fisher Scientific
    BIOGRAPHY
    • Part 1: Clinical Research in Myeloid Malignancies
    • Experiences with the OncomineTM Myeloid Assay v2 and the Analytical Validation Service in clinical research
      MAR 21, 2024 3:05 PM CET

      Experiences with the OncomineTM Myeloid Assay v2 and the Analytical Validation Service in clinical research

      Maximilian Prinz-Wohlgenannt, BSc, MSc
      Head of Molecular Biology, Landesklinikum Horn - Allentsteig, Horn, Austria
      BIOGRAPHY
      Continuing Education: P.A.C.E. CE | Florida CE
    • Part 2: Haematological Malignancies General Education
    • A high-throughput NGS screen for myeloproliferative neoplasms (MPN)
      MAR 21, 2024 3:35 PM CET

      A high-throughput NGS screen for myeloproliferative neoplasms (MPN)

      Dr. Daniel Lock, PhD
      Clinical Scientist, LTHT Hematological Malignancy Diagnostic Service, Leeds, England, UK
      BIOGRAPHY
      Continuing Education: P.A.C.E. CE | Florida CE
  • Americas Live Session: 12:00-13:35 PT
  • Welcome
    MAR 21, 2024 12:00 PM PDT

    Welcome

    Moderator | Luca Quagliata, PhD, MCMAS, COA
    Vice President and Global Head of Medical Affairs, Thermo Fisher Scientific
    BIOGRAPHY
    • AMER, Part 1: General Education
    • An experience with in-house NGS for solid tumor testing
      MAR 21, 2024 12:05 PM PDT

      An experience with in-house NGS for solid tumor testing

      Dr. Wang Cheung, MD PhD
      Pathologist, Orlando Regional Hospital, Orlando, FL, USA
      Continuing Education: P.A.C.E. CE | Florida CE
    • Community-based testing experiences with the GeneStrat NGS liquid biopsy test
      MAR 21, 2024 12:30 PM PDT

      Community-based testing experiences with the GeneStrat NGS liquid biopsy test

      Gary Pestano, PhD
      Chief Development Officer, NYS CLEP Laboratory Director, Biodesix Inc., Louisville, CO
      BIOGRAPHY
      Continuing Education: P.A.C.E. CE | Florida CE
    • Empowering precision oncology through localized comprehensive genomic tumor profiling
      MAR 21, 2024 1:05 PM PDT

      Empowering precision oncology through localized comprehensive genomic tumor profiling

      Andrea Ferreira-Gonzalez, PhD
      Professor of Pathology, Chair of Molecular Diagnostics Division, Virginia Commonwealth University, Richmond, Virginia, USA
      Continuing Education: P.A.C.E. CE | Florida CE

Speakers


  • Moderator | Philip Jermann, PhD

    Moderator | Philip Jermann, PhD

    CSD Medical Affairs Director EMEA, Thermo Fisher Scientific

    BIOGRAPHY
  • Moderator | Luca Quagliata, PhD, MCMAS, COA

    Moderator | Luca Quagliata, PhD, MCMAS, COA

    Vice President and Global Head of Medical Affairs, Thermo Fisher Scientific

    BIOGRAPHY
  • Dr. Glenn Francis, MBBS(Hons) FRCPA MBA FFSc(RCPA) PhD

    Dr. Glenn Francis, MBBS(Hons) FRCPA MBA FFSc(RCPA) PhD

    Medical Director, Genomics for Life, Queensland, Australia

    BIOGRAPHY
  • Dr. Ting Chan, PhD

    Dr. Ting Chan, PhD

    Curation Scientist, Centre for Cancer Research, University of Melbourne, Melbourne, Australia

    BIOGRAPHY
  • Dr. Michael Krigstein, MBBS(Hons) FRACP FRCPA MCncrSc

    Dr. Michael Krigstein, MBBS(Hons) FRACP FRCPA MCncrSc

    Consultant Haematologist, SydPath, St Vincent's Hospital, Sydney, Australia

    BIOGRAPHY
  • Dr. James Beasley, DClinSci, MSc

    Dr. James Beasley, DClinSci, MSc

    Principal Clinical Scientist, West Midlands Regional Genetics Service, Birmingham, England, UK

    BIOGRAPHY
  • Maximilian Prinz-Wohlgenannt, BSc, MSc

    Maximilian Prinz-Wohlgenannt, BSc, MSc

    Head of Molecular Biology, Landesklinikum Horn - Allentsteig, Horn, Austria

    BIOGRAPHY
  • Dr. Nicola Normanno, MD

    Dr. Nicola Normanno, MD

    Scientific Director, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST), "Dino Amadori", Meldola, Italy

    BIOGRAPHY
  • Dr. Daniel Lock, PhD

    Dr. Daniel Lock, PhD

    Clinical Scientist, LTHT Hematological Malignancy Diagnostic Service, Leeds, England, UK

    BIOGRAPHY
  • Dr. Philip Sander, Dr rer nat

    Dr. Philip Sander, Dr rer nat

    Laboratory Manager, NGS Diagnostics, T-BAG Molecular Pathology Baden-Württemberg, Stuttgart, Germany

    BIOGRAPHY
  • Dr. Wang Cheung, MD PhD

    Dr. Wang Cheung, MD PhD

    Pathologist, Orlando Regional Hospital, Orlando, FL, USA

  • Gary Pestano, PhD

    Gary Pestano, PhD

    Chief Development Officer, NYS CLEP Laboratory Director, Biodesix Inc., Louisville, CO

    BIOGRAPHY
  • Andrea Ferreira-Gonzalez, PhD

    Andrea Ferreira-Gonzalez, PhD

    Professor of Pathology, Chair of Molecular Diagnostics Division, Virginia Commonwealth University, Richmond, Virginia, USA

Help

Demographics

Connect with us